TrimRx's Blog
Tirzepatide Results After Week 1: Realistic Weight Loss Expectations
You’\”ve done your first tirzepatide injection. The starter dose is 2.5 mg, the side effects have shown up, and the scale has moved a little.
Tirzepatide Results After Month 3: Realistic Weight Loss Expectations
Twelve weeks on tirzepatide. You’\”ve cleared three titrations, you’\”re wrapping up the 7.5 mg cycle, and the trajectory is now clear.
Tirzepatide Results After Month 2: Realistic Weight Loss Expectations
Eight weeks on tirzepatide.
Tirzepatide Results After 1 Year: Realistic Weight Loss Expectations
A full year of tirzepatide. Fifty-two weekly injections, multiple dose adjustments, behavioral resets, and a slow but real shift in baseline.
Tirzepatide Results After Month 1: Realistic Weight Loss Expectations
Four weeks of tirzepatide. You’\”re about to move from 2.5 mg to 5 mg, which is where the drug starts doing meaningful work.
Can You Take Tirzepatide Long-Term?
Yes. Tirzepatide is FDA-approved for chronic use in both type 2 diabetes (Mounjaro) and obesity (Zepbound).
Tirzepatide Latest Research: New Indications, Trials & What’s Coming
The original tirzepatide trials targeted type 2 diabetes (SURPASS program) and obesity (SURMOUNT program).
When Will Tirzepatide Go Generic? Patent Timeline & Biosimilar Outlook
Tirzepatide (Mounjaro for diabetes, Zepbound for obesity) is Eli Lilly’s blockbuster dual GIP/GLP-1 receptor agonist. SURMOUNT-1 (Jastreboff et al.
Tirzepatide Who Should (and Shouldn’t) Take It: Eligibility & Contraindications
Introduction Tirzepatide has three FDA-approved indications as of 2026: type 2 diabetes (Mounjaro®), chronic weight management in adults with BMI 30+ or BMI 27+…
